Page last updated: 2024-12-04

phosphoglycolate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

phosphoglycolate: RN given refers to parent acid [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

2-phosphoglycolic acid : The O-phospho derivative of glycolic acid. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID529
CHEMBL ID47181
CHEBI ID17150
SCHEMBL ID380471
MeSH IDM0060771

Synonyms (44)

Synonym
(phosphonooxy)acetic acid
CHEBI:17150 ,
2-phosphoglycolic acid
glycophosphoric acid
glycolic acid, dihydrogen phosphate
glycolic acid phosphate
13147-57-4
glycolic acid, di-h phosphate
acetic acid, (phosphonooxy)-
C00988
phosphoglycolic acid
phosphoglycolate
1AW1
1LZO
1ML1
1LYX
1EGH
1PDZ
1S89
1HTI
2YPI
1KV5
DB02726
glycolic acid-2-phosphate
6FB3806D-D746-4CF2-ACC9-B2596CFFA5A4
2-phosphoglycolatephosphonooxy-acetic acid
CHEMBL47181
phosphonooxy-acetic acid anion
2-phosphonooxyacetic acid
unii-h8593jop13
h8593jop13 ,
einecs 236-084-2
ASCFNMCAHFUBCO-UHFFFAOYSA-N
SCHEMBL380471
acetic acid, 2-(phosphonooxy)-
DTXSID60157064
2-(phosphonooxy)acetic acid
glycophosphorate
glycolic acid di-h phosphate
(phosphonooxy)-acetate
(phosphonooxy)acetate
glycolic acid dihydrogen phosphate
(phosphonooxy)-acetic acid
Q2823206

Research Excerpts

Overview

Phosphoglycolate (PG) is a competitive inhibitor of enolase.

ExcerptReferenceRelevance
"Phosphoglycolate (PG) is a competitive inhibitor of enolase."( Inhibition of enolase: the crystal structures of enolase-Ca2(+)- 2-phosphoglycerate and enolase-Zn2(+)-phosphoglycolate complexes at 2.2-A resolution.
Brewer, JM; Lebioda, L; Stec, B; Tykarska, E, 1991
)
1.22
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
Escherichia coli metaboliteAny bacterial metabolite produced during a metabolic reaction in Escherichia coli.
mouse metaboliteAny mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
carboxyalkyl phosphate
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (2)

PathwayProteinsCompounds
Photosynthetic carbon reduction014
PCO cycle824

Protein Targets (13)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, TRIOSEPHOSPHATE ISOMERASEMoritella marinaKi89,000.000089,000.000089,000.000089,000.0000AID977610
Chain A, METHYLGLYOXAL SYNTHASEEscherichia coliKi2.00002.00002.00002.0000AID977610
Chain F, METHYLGLYOXAL SYNTHASEEscherichia coliKi2.00002.00002.00002.0000AID977610
Chain A, TRIOSEPHOSPHATE ISOMERASEHomo sapiens (human)Ki7.40007.40007.40007.4000AID977610
Chain B, TRIOSEPHOSPHATE ISOMERASEHomo sapiens (human)Ki7.40007.40007.40007.4000AID977610
Chain A, triosephosphate isomerase, glycosomalTrypanosoma brucei bruceiKi60.000060.000060.000060.0000AID977610
Chain A, Triosephosphate IsomerasePlasmodium falciparum (malaria parasite P. falciparum)Ki29.000029.000029.000029.0000AID977610
Chain B, Triosephosphate IsomerasePlasmodium falciparum (malaria parasite P. falciparum)Ki29.000029.000029.000029.0000AID977610
Chain A, Triosephosphate IsomeraseTrypanosoma brucei bruceiKi52.000052.000052.000052.0000AID977610
Chain A, EnolaseHomarus gammarus (European lobster)Ki200.0000200.0000200.0000200.0000AID977610
Chain A, Methylglyoxal synthaseEscherichia coliKi5.80005.80005.80005.8000AID977610
Chain F, Methylglyoxal synthaseEscherichia coliKi5.80005.80005.80005.8000AID977610
Chain A, Triosephosphate IsomeraseSaccharomyces cerevisiae (brewer's yeast)Ki15.000015.000015.000015.0000AID977610
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (21)

Assay IDTitleYearJournalArticle
AID977610Experimentally measured binding affinity data (Ki) for protein-ligand complexes derived from PDB2002FEBS letters, May-08, Volume: 518, Issue:1-3
The importance of the conserved Arg191-Asp227 salt bridge of triosephosphate isomerase for folding, stability, and catalysis.
AID1811Experimentally measured binding affinity data derived from PDB2002FEBS letters, May-08, Volume: 518, Issue:1-3
The importance of the conserved Arg191-Asp227 salt bridge of triosephosphate isomerase for folding, stability, and catalysis.
AID977610Experimentally measured binding affinity data (Ki) for protein-ligand complexes derived from PDB2002Biochemistry, Nov-05, Volume: 41, Issue:44
Structure of the Plasmodium falciparum triosephosphate isomerase-phosphoglycolate complex in two crystal forms: characterization of catalytic loop open and closed conformations in the ligand-bound state.
AID1811Experimentally measured binding affinity data derived from PDB2002Biochemistry, Nov-05, Volume: 41, Issue:44
Structure of the Plasmodium falciparum triosephosphate isomerase-phosphoglycolate complex in two crystal forms: characterization of catalytic loop open and closed conformations in the ligand-bound state.
AID977610Experimentally measured binding affinity data (Ki) for protein-ligand complexes derived from PDB2004Biochemistry, Apr-06, Volume: 43, Issue:13
Mutagenic studies on histidine 98 of methylglyoxal synthase: effects on mechanism and conformational change.
AID1811Experimentally measured binding affinity data derived from PDB2004Biochemistry, Apr-06, Volume: 43, Issue:13
Mutagenic studies on histidine 98 of methylglyoxal synthase: effects on mechanism and conformational change.
AID977610Experimentally measured binding affinity data (Ki) for protein-ligand complexes derived from PDB1995Biochemistry, Oct-03, Volume: 34, Issue:39
X-ray structure and catalytic mechanism of lobster enolase.
AID1811Experimentally measured binding affinity data derived from PDB1995Biochemistry, Oct-03, Volume: 34, Issue:39
X-ray structure and catalytic mechanism of lobster enolase.
AID977610Experimentally measured binding affinity data (Ki) for protein-ligand complexes derived from PDB2000Biochemistry, Mar-21, Volume: 39, Issue:11
Mirroring perfection: the structure of methylglyoxal synthase complexed with the competitive inhibitor 2-phosphoglycolate.
AID1811Experimentally measured binding affinity data derived from PDB2000Biochemistry, Mar-21, Volume: 39, Issue:11
Mirroring perfection: the structure of methylglyoxal synthase complexed with the competitive inhibitor 2-phosphoglycolate.
AID1811Experimentally measured binding affinity data derived from PDB1990Biochemistry, Jul-17, Volume: 29, Issue:28
Crystallographic analysis of the complex between triosephosphate isomerase and 2-phosphoglycolate at 2.5-A resolution: implications for catalysis.
AID977610Experimentally measured binding affinity data (Ki) for protein-ligand complexes derived from PDB1990Biochemistry, Jul-17, Volume: 29, Issue:28
Crystallographic analysis of the complex between triosephosphate isomerase and 2-phosphoglycolate at 2.5-A resolution: implications for catalysis.
AID977610Experimentally measured binding affinity data (Ki) for protein-ligand complexes derived from PDB1997Protein engineering, Feb, Volume: 10, Issue:2
Protein engineering with monomeric triosephosphate isomerase (monoTIM): the modelling and structure verification of a seven-residue loop.
AID1811Experimentally measured binding affinity data derived from PDB1997Protein engineering, Feb, Volume: 10, Issue:2
Protein engineering with monomeric triosephosphate isomerase (monoTIM): the modelling and structure verification of a seven-residue loop.
AID977610Experimentally measured binding affinity data (Ki) for protein-ligand complexes derived from PDB1998The Journal of biological chemistry, Jan-23, Volume: 273, Issue:4
Triose-phosphate isomerase (TIM) of the psychrophilic bacterium Vibrio marinus. Kinetic and structural properties.
AID1811Experimentally measured binding affinity data derived from PDB1998The Journal of biological chemistry, Jan-23, Volume: 273, Issue:4
Triose-phosphate isomerase (TIM) of the psychrophilic bacterium Vibrio marinus. Kinetic and structural properties.
AID227718Binding energy by using the equation deltaG obsd = -RT ln KD1984Journal of medicinal chemistry, Dec, Volume: 27, Issue:12
Functional group contributions to drug-receptor interactions.
AID221770Effective concentration to activate gammadelta T cells2002Journal of medicinal chemistry, Oct-24, Volume: 45, Issue:22
Quantitative structure--activity relations for gammadelta T cell activation by phosphoantigens.
AID210157Binding affinity against TP isomerase2002Journal of medicinal chemistry, Jun-20, Volume: 45, Issue:13
SMall Molecule Growth 2001 (SMoG2001): an improved knowledge-based scoring function for protein-ligand interactions.
AID977610Experimentally measured binding affinity data (Ki) for protein-ligand complexes derived from PDB1994Protein science : a publication of the Protein Society, May, Volume: 3, Issue:5
Crystal structure of recombinant human triosephosphate isomerase at 2.8 A resolution. Triosephosphate isomerase-related human genetic disorders and comparison with the trypanosomal enzyme.
AID1811Experimentally measured binding affinity data derived from PDB1994Protein science : a publication of the Protein Society, May, Volume: 3, Issue:5
Crystal structure of recombinant human triosephosphate isomerase at 2.8 A resolution. Triosephosphate isomerase-related human genetic disorders and comparison with the trypanosomal enzyme.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (129)

TimeframeStudies, This Drug (%)All Drugs %
pre-199018 (13.95)18.7374
1990's36 (27.91)18.2507
2000's38 (29.46)29.6817
2010's33 (25.58)24.3611
2020's4 (3.10)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 43.66

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index43.66 (24.57)
Research Supply Index4.87 (2.92)
Research Growth Index4.67 (4.65)
Search Engine Demand Index63.12 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (43.66)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews6 (4.65%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other123 (95.35%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]